CP
ADMA icon

Caligan Partners’s ADMA Biologics ADMA Stock Holding History

Caligan Partners’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.9M Buy
4,756,511
+1,744,003
+58% +$27.5M 3.03% 12
2025
Q4 		$54.9M Buy
3,012,508
+375,899
+14% +$6.34M 5.03% 8
2025
Q3 		$38.7M Buy
+2,636,609
New +$45.2M 5.36% 8
2024
Q1 		– Sell
-473,087
Closed -$2.14M – 13
2023
Q4 		$2.14M Sell
473,087
-124,426
-21% -$460K 0.72% 10
2023
Q3 		$2.14M Sell
597,513
-250,000
-29% -$962K 1.09% 9
2023
Q2 		$3.13M Sell
847,513
-815,100
-49% -$3.02M 1.9% 9
2023
Q1 		$5.5M Sell
1,662,613
-1,013,480
-38% -$3.5M 3.84% 6
2022
Q4 		$10.4M Buy
+2,676,093
New +$8.25M 8.64% 4

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return